[go: up one dir, main page]

DE69727915D1 - Substituierte vinylpyridinderivate und arzneimittel, die diese enthalten - Google Patents

Substituierte vinylpyridinderivate und arzneimittel, die diese enthalten

Info

Publication number
DE69727915D1
DE69727915D1 DE69727915T DE69727915T DE69727915D1 DE 69727915 D1 DE69727915 D1 DE 69727915D1 DE 69727915 T DE69727915 T DE 69727915T DE 69727915 T DE69727915 T DE 69727915T DE 69727915 D1 DE69727915 D1 DE 69727915D1
Authority
DE
Germany
Prior art keywords
derivative
salt
group
products containing
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69727915T
Other languages
English (en)
Other versions
DE69727915T2 (de
Inventor
Kazuo Yamazaki
Yoichiro Ogawa
Hidehiko Kohya
Tadashi Mikami
Noriyuki Kawamoto
Noriaki Shioiri
Hiroshi Hasegawa
Susumu Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of DE69727915D1 publication Critical patent/DE69727915D1/de
Publication of DE69727915T2 publication Critical patent/DE69727915T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE69727915T 1996-09-25 1997-09-22 Substituierte vinylpyridinderivate und arzneimittel, die diese enthalten Expired - Fee Related DE69727915T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25294496 1996-09-25
JP25294496 1996-09-25
PCT/JP1997/003354 WO1998013348A1 (fr) 1996-09-25 1997-09-22 Derives de vinylpiridine substitues et medicaments les contenant

Publications (2)

Publication Number Publication Date
DE69727915D1 true DE69727915D1 (de) 2004-04-08
DE69727915T2 DE69727915T2 (de) 2004-08-19

Family

ID=17244339

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69727915T Expired - Fee Related DE69727915T2 (de) 1996-09-25 1997-09-22 Substituierte vinylpyridinderivate und arzneimittel, die diese enthalten

Country Status (9)

Country Link
US (1) US5935977A (de)
EP (1) EP0882714B1 (de)
KR (1) KR100517452B1 (de)
CN (1) CN1169792C (de)
AT (1) ATE260898T1 (de)
DE (1) DE69727915T2 (de)
ES (1) ES2217428T3 (de)
TW (1) TW517056B (de)
WO (1) WO1998013348A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7267094A (en) 1993-07-28 1995-02-28 Rhone-Poulenc Rorer Limited Compounds as pde iv and tnf inhibitors
US6368815B1 (en) 1999-03-29 2002-04-09 Warner-Lambert Company Screening of molecules that inhibit human phosphodiesterase 4A produced by non-recombinant cell lines
ATE312820T1 (de) * 1999-10-28 2005-12-15 Trine Pharmaceuticals Inc Pumpeninhibitoren zur freisetzung von medikamenten
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
CA2445697A1 (en) * 2001-04-26 2002-11-07 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
SG2011076551A (en) 2001-06-26 2015-08-28 Amgen Inc Antibodies to opgl
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
JPWO2003086396A1 (ja) * 2002-04-02 2005-08-18 株式会社ツムラ ピリジルアクリル酸アミド誘導体を含有するホスホジエステラーゼiv阻害剤
WO2004060911A2 (en) 2002-12-30 2004-07-22 Amgen Inc. Combination therapy with co-stimulatory factors
EP1594863A1 (de) * 2003-02-11 2005-11-16 Prosidion Limited Tricyclo-substituierte amid glucokinase-aktivatoren
GB0411562D0 (en) 2004-05-24 2004-06-23 Sterix Ltd Compound
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
GB0702446D0 (en) 2007-02-08 2007-03-21 Sterix Ltd Composition
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
KR101599804B1 (ko) * 2012-08-28 2016-03-04 (주)로커스 관 삽입 확인장치 및 관을 대상물에 연결시키는 방법
EP2935239B1 (de) * 2012-11-28 2018-08-29 Sanofi Verfahren zur herstellung von 4-(cyclopropylmethoxy)-n-(3,5-dichlor-1-oxido-4-pyridyl)-5-methoxypyridin-2-carboxamid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673684A (en) * 1984-04-04 1987-06-16 Terumo Corporation Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9401460D0 (en) * 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
KR100257550B1 (ko) * 1996-03-15 2000-07-01 타이도 나오카타 신규 피리딘 유도체 및 이를 유효성분으로 하는 의약

Also Published As

Publication number Publication date
CN1206407A (zh) 1999-01-27
TW517056B (en) 2003-01-11
DE69727915T2 (de) 2004-08-19
ES2217428T3 (es) 2004-11-01
EP0882714A1 (de) 1998-12-09
KR19990067377A (ko) 1999-08-16
WO1998013348A1 (fr) 1998-04-02
KR100517452B1 (ko) 2007-03-15
CN1169792C (zh) 2004-10-06
EP0882714B1 (de) 2004-03-03
US5935977A (en) 1999-08-10
ATE260898T1 (de) 2004-03-15
EP0882714A4 (de) 2000-02-09

Similar Documents

Publication Publication Date Title
DE69727915D1 (de) Substituierte vinylpyridinderivate und arzneimittel, die diese enthalten
EA200601192A1 (ru) ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 8'-ПИРИ(МИ)ДИНИЛДИГИДРОСПИРО[ЦИКЛОАЛКИЛАМИН]ПИРИМИДО[1,2-a]ПИРИМИДИН-6-ОНА
ATE164575T1 (de) Substituierte aromatische verbindungen als c. amp phosphodiesterase-und tnf-hemmer
TW200510418A (en) Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido [1, 2-a] pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido [1, 2-a] pyrimidin-6-one derivatives
WO2004082577A3 (en) 8-SUBSTITUTED-6, 7, 8, 9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
NO882036D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner.
HUP0401889A2 (hu) 1,8-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények
DE69733825D1 (de) Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern
NO985864L (no) Nye anti-virale forbindelser
NO20054331L (no) Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
EP1396493A4 (de) Heterocyclische verbindungen
HUT63598A (en) Process for producing phenyl cycloalkyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient
EA200970455A1 (ru) ЗАМЕЩЕННЫЙ 8-ПИПЕРИДИНИЛ-2-ПИРИДИНИЛПИРИМИДО[1,2-a]ПИРИМИДИН-6-ОН И ПРОИЗВОДНЫЕ 8-ПИПЕРИДИНИЛ-2-ПИРИМИДИНИЛПИРИМИДО[1,2-a]ПИРИМИДИН-6-ОНА
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
IL148875A0 (en) Sulfonyl hydrazide derivatives, their preparation and pharmaceutical compositions containing them
ATE420853T1 (de) 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung
MX9206093A (es) Derivado de oxazolidona
DK0780125T3 (da) Anvendelse af hydantoinderivater til fremstilling af et lægemiddel til behandling af sygdomme associeret med tilstedeværelse af aktivt oxygen og frie radikaler
EA200300150A1 (ru) ПРОИЗВОДНЫЕ 1-[АЛКИЛ], 1-[(ГЕТЕРОАРИЛ)АЛКИЛ] И 1-[(АРИЛ)АЛКИЛ]-7-ПИРИДИНИЛ-ИМИДАЗО[1, 2-a]ПИРИМИДИН-5(1H)ОНА
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
CA2236851A1 (en) Substituted vinylpyridine derivatives and drugs containing the same
RU94033470A (ru) Циклогексановые производные, фармкомпозиция на их основе и способ лечения
DE602004019508D1 (de) Diaminderivat, herstellungsverfahren und antioxidations-arzneimittel
PT1315731E (pt) Derivados de 2-piridinil-6,7,8,9-tetra-hidropirimido [1,2-a] pirimidin-4-ona e 7-piridinil-2,3-di-hidroimidazol [1,2-a]pirimidin-5 (1h) ona
RU2004110412A (ru) Производные циклических индолов и гетероиндолов, способы их получения и применение их в качестве лекарственных средств

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOMEDIX CO., LTD, TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: HISAMITSU MEDICAL CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: HISAMITSU PHARMACEUTICAL CO., INC., TOSU, SAGA, JP

8339 Ceased/non-payment of the annual fee